These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29349834)

  • 21. Development and evaluation of a self-report tool to predict low pharmacy refill adherence in elderly patients with uncontrolled hypertension.
    Krousel-Wood M; Joyce C; Holt EW; Levitan EB; Dornelles A; Webber LS; Muntner P
    Pharmacotherapy; 2013 Aug; 33(8):798-811. PubMed ID: 23649849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension.
    Hwang AY; Dave CV; Smith SM
    Am J Hypertens; 2018 Nov; 31(12):1324-1331. PubMed ID: 30052747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014.
    Ritchey M; Tsipas S; Loustalot F; Wozniak G
    PLoS One; 2016; 11(7):e0159366. PubMed ID: 27428008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis.
    Du LP; Cheng ZW; Zhang YX; Li Y; Mei D
    J Clin Hypertens (Greenwich); 2018 May; 20(5):902-907. PubMed ID: 29700923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between pharmacy refill-adherence metrics and healthcare utilisation: a prospective cohort study of older hypertensive adults.
    Dillon P; Smith SM; Gallagher P; Cousins G
    Int J Pharm Pract; 2019 Oct; 27(5):459-467. PubMed ID: 30968988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A concept-wide association study to identify potential risk factors for nonadherence among prevalent users of antihypertensives.
    Singh K; Choudhry NK; Krumme AA; McKay C; McElwee NE; Kimura J; Franklin JM
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1299-1308. PubMed ID: 31313427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension.
    Steiner JF; Ho PM; Beaty BL; Dickinson LM; Hanratty R; Zeng C; Tavel HM; Havranek EP; Davidson AJ; Magid DJ; Estacio RO
    Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):451-7. PubMed ID: 20031876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
    Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P
    Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
    Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
    Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation.
    Melzer AC; Uman J; Au DH
    Ann Am Thorac Soc; 2015 Jun; 12(6):831-7. PubMed ID: 25849224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG
    Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension.
    de la Sierra A; Armario P; Oliveras A; Banegas JR; Gorostidi M; Vinyoles E; de la Cruz JJ; Segura J; Ruilope LM
    J Hypertens; 2018 Jul; 36(7):1563-1570. PubMed ID: 29601411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.
    Ho PM; Magid DJ; Shetterly SM; Olson KL; Peterson PN; Masoudi FA; Rumsfeld JS
    Arch Intern Med; 2008 Feb; 168(3):271-6. PubMed ID: 18268167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.
    Suzuki H; Shimada Y; Fujiwara K
    Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):237-44. PubMed ID: 23129531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.
    Schulz M; Krueger K; Schuessel K; Friedland K; Laufs U; Mueller WE; Ude M
    Int J Cardiol; 2016 Oct; 220():668-76. PubMed ID: 27393848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
    Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological control of diabetes and hypertension comorbidity in the elderly: A study of "real world" data.
    Foguet-Boreu Q; Violán C; López Jiménez T; Pons-Vigués M; Rodríguez-Blanco T; Valderas JM; Guisado Clavero M; Pujol-Ribera E
    Prim Care Diabetes; 2017 Aug; 11(4):348-359. PubMed ID: 28457898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
    Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive control and new-onset atrial fibrillation: Results from the Swedish Primary Care Cardiovascular Database (SPCCD).
    Mourtzinis G; Schiöler L; Kahan T; Bengtsson Boström K; Hjerpe P; Hasselström J; Manhem K
    Eur J Prev Cardiol; 2017 Jul; 24(11):1206-1211. PubMed ID: 28470087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.